Skip to main content Skip to main navigation menu Skip to site footer

Abstract

Introduction: Anal fissure is shallow tear in the anoderm distal to dentate line which is considered most common proctologic condition.  Anal fissure is generally located in the posterior midline. The symptoms include anal pain, spasm, and/or bleeding during defecation1. The pain can be so intense as to induce the patient to avoid defecation with consequent hardening of the feces and exacerbation of the problem2. Management of the anal fissure is improving diet and defecation habit, medical therapy and surgical therapy. The goal of medical treatment for chronic anal fissure is to temporarily reduce pressure of the anal canal to facilitate the healing of the fissure (“reversible sphincterotomy”), thereby reducing muscle tone. Intrasphincteric Botulinum Toxin A injection seems to be a reliable option.

Case reports: two male patients were diagnosed with anal fissures, the patients complained of pain and spasm. They were treated with  botulinum toxin type A (100 unit AllergenÒ), injected  into three sites of the internal sphincter at 2, 5 and 8 o’clock. The symptoms relieved and the anal fissure healed within one month. There was no sign of relapse or incontinence during 12 months of follow-up.

Conclusion: Botulinum toxin therapy can be considered as efficacious, effective and safe treatment for anal fissures.

 

Keywords: anal fissure, botox, botulinum toxin, intrasphincteric

References

  1. Hananel N, Gordon PH. Re-examination of clinical manifestations and response to therapy of fissure-in-ano. Dis Colon & Rectum. 1997;40(2):229–33. Available from: http://dx.doi.org/10.1007/bf02054993
  2. American Gastroenterological Association medical position statement: Diagnosis and care of patients with anal fissure, This document presents the official recommendations of the American Gastroenterological Association (AGA) on Anal Fissures. It was approved by the Clinical Practice Committee on May 19, 2002 and by the AGA Governing Board on July 27, 2002. Gastroenterology. 2003;124(1):233–4. Available from: http://dx.doi.org/10.1053/gast.2003.50006
  3. Lockhart-Mummery HE. Surgery of the anus, rectum and colon. J. C. Goligher, Leeds, with the collaboration of H. L. Duthie, Sheffield, and H. H. Nixon, London. Third edition. 190 × 250 mm. Pp. 1164 + viii, with 608 illustrations. 1975. London: Baillière Tindall. £21. Br J Surg. 1976;63(3):252. Available from: http://dx.doi.org/10.1002/bjs.1800630326
  4. Cross KLR, Massey EJD, Fowler AL, Monson JRT. The Management of Anal Fissure: ACPGBI Position Statement. Color Dis. 2008;10:1–7. Available from: http://dx.doi.org/10.1111/j.1463-1318.2008.01681.x
  5. Schouten WR, Briel JW, Auwerda JJA. Relationship between anal pressure and anodermal blood flow. Dis Colon & Rectum. 1994;37(7):664–9. Available from: http://dx.doi.org/10.1007/bf02054409
  6. Pilkington SA, Bhome R, Welch RE, Ku F, Warden C, Harris S, et al. Bilateral versus unilateral botulinum toxin injections for chronic anal fissure: a randomised trial. Tech Coloproctol. 2018/07/18. 2018;22(7):545–51. Available from: https://pubmed.ncbi.nlm.nih.gov/30022331
  7. Jost WH, Schimrigk K. Use of botulinum toxin in anal fissure. Dis Colon & Rectum. 1993;36(10):974. Available from: http://dx.doi.org/10.1007/bf02050639
  8. Brisinda G, Maria G. Botulinum Toxin in the Treatment of Chronic Anal Fissure. Dis Colon & Rectum. 2003;46(8):1144–7. Available from: http://dx.doi.org/10.1007/s10350-004-7296-4
  9. Menteş BB, İrkörücü O, Akn M, Leventoğlu S, Tatlcoğlu E. Comparison of Botulinum Toxin Injection and Lateral Internal Sphincterotomy for the Treatment of Chronic Anal Fissure. Dis Colon & Rectum. 2003;46(2):232–7. Available from: http://dx.doi.org/10.1007/s10350-004-6528-y
  10. Tilney HS, Heriot AG, Cripps NPJ. Complication of botulinum toxin injections for anal fissure. Dis Colon & Rectum. 2001;44(11):1721. Available from: http://dx.doi.org/10.1007/bf02234399
  11. Brisinda G, Maria G, Sganga G, Bentivoglio AR, Albanese A, Castagneto M. Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery. 2002;131(2):179–84. Available from: http://dx.doi.org/10.1067/msy.2002.119314
  12. Siproudhis L, Sébille V, Pigot F, Hémery P, Juguet F, Bellissant E. Lack of effficacy of botulinum toxin in chronic anal fissure. Aliment Pharmacol & Ther. 2003;18(5):515–24. Available from: http://dx.doi.org/10.1046/j.1365-2036.2003.01467.x
  13. Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. Am J Surg. 2000;179(1):46–50. Available from: http://dx.doi.org/10.1016/s0002-9610(99)00255-x
  14. Arroyo A, Perez F, Serrano P, Candela F, Calpena R. Long-term results of botulinum toxin for the treatment of chronic anal fissure: prospective clinical and manometric study. Int J Colorectal Dis. 2004;20(3):267–71. Available from: http://dx.doi.org/10.1007/s00384-004-0644-y

How to Cite

Antara, G. E. R. (2022). Botox injection for anal fissure management: case report. Intisari Sains Medis, 13(2), 443–445. https://doi.org/10.15562/ism.v13i2.1387

HTML
0

Total
0

Share

Search Panel

Gede Eka Rusdi Antara
Google Scholar
Pubmed
ISM Journal